To further clarify the relationship between hypoxia signaling and chemoresistance, a siRNA approach was used to silence HIF-2α in a TMZ-treated GBM cell line, resulting in a reduction in chemotherapeutic resistance and neurosphere formation [61]. Here, EPAS1 is linked to glioblastoma.